Buy Fresenius Kabi Oncology with a target of 108: Sandeep Wagle

Fresenius Kabi Oncology Ltd is a ‘BUY’ call with a target of Rs 108 and a stop loss of Rs 92.50.

| Updated: Sep 12, 2012, 10.40 AM IST

In a chat with ET Now, Sandeep Wagle, founder & MD, APTART Technical Advisory Services, shares his views on Fresenius Kabi Oncology.

ET Now: What is the call on Fresenius Kabi Oncology?

Sandeep Wagle: Fresenius Kabi Oncology Ltd is a ‘BUY’ call with a target of Rs 108 and a stop loss of Rs 92.50.

Not making enough money in stocks? Click here for real-life stories of successful investors.

Too busy to trade in stocks? Invest in Mutual Funds with ET Money!